Evidence map›Paper›PMID 33062843›Full record

ArticleTransplantation direct2020

Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study.

Raphael P H Meier, Hiroshi Noguchi, Yvonne M Kelly, Minnie Sarwal, Giulia Conti, Casey Ward, Ran Halleluyan, Mehdi Tavakol, Peter G Stock, Chris E Freise

Open access · goldAbstract read
In one paragraph

Article in Transplantation direct, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Raphael P H MeierDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Hiroshi NoguchiDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Yvonne M KellyDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Minnie SarwalDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Giulia ContiDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Casey WardDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Ran HalleluyanDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Mehdi TavakolDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Peter G StockDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
Chris E FreiseDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA.
University of California, San Francisco · USKyushu University · JP

Funding

Filling a Void of Research (FAVOR) Training for Transplant SurgeonsT32AI125222 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER G STOCK, Minnie M Sarwal · 2016 to 2026
$3.4M
NIAID NIH HHS T32 AI125222
6 · The paper itself

Abstract

backgroundSarcopenia has been identified as a predictive variable for surgical outcomes. We hypothesized that sarcopenia could be a key measure to identify frail patients and potentially predict poorer outcomes among recipients of simultaneous pancreas and kidney (SPK) transplants.

methodsWe estimated sarcopenia by measuring psoas muscle mass index (PMI). PMI was assessed on perioperative computed tomography (CT) scans of SPK recipients.

resultsOf the 141 patients identified between 2010 and 2018, 107 had a CT scan available and were included in the study. The median follow-up was 4 years (range, 0.5-9.1 y). Twenty-three patients had a low PMI, and 84 patients had a normal PMI. Patient characteristics were similar between the 2 groups except for body mass index, which was significantly lower in low PMI group (

conclusionSarcopenia could represent one of the predictors of pancreas graft failure and should be evaluated and potentially optimized in SPK recipients.

Identifiers

PMID33062843
PMCPMC7523826
OpenAlexW3081613941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.